Pharmacological Targeting of BET Bromodomains Inhibits Lens Fibrosis via Downregulation of MYC Expression.

MLA

Wang, Xiaoran, et al. “Pharmacological Targeting of BET Bromodomains Inhibits Lens Fibrosis via Downregulation of MYC Expression.” Investigative Ophthalmology & Visual Science, vol. 60, no. 14, Nov. 2019, pp. 4748–58. EBSCOhost, https://doi.org/10.1167/iovs.19-27596.

APA

Wang, X., Wang, B., Zhao, N., Wang, C., Huang, M., Chen, B., Chen, J., Sun, Y., Xiong, L., Huang, S., & Liu, Y. (2019). Pharmacological Targeting of BET Bromodomains Inhibits Lens Fibrosis via Downregulation of MYC Expression. Investigative Ophthalmology & Visual Science, 60(14), 4748–4758. https://doi.org/10.1167/iovs.19-27596

Chicago

Wang, Xiaoran, Bowen Wang, Na Zhao, Chenjie Wang, Mi Huang, Baoxin Chen, Jieping Chen, et al. 2019. “Pharmacological Targeting of BET Bromodomains Inhibits Lens Fibrosis via Downregulation of MYC Expression.” Investigative Ophthalmology & Visual Science 60 (14): 4748–58. doi:10.1167/iovs.19-27596.